TD Cowen reiterates Edwards Lifesciences stock Buy rating on TAVR growth
Covered in this story
What has happened since
- Edwards Lifesciences is down 0.4% since this was published, 79 days ago.
Price move measured from the close nearest publication to the latest quote.
Tracked from this story
TD Cowen’s $104 target on $EW is on the record and being tracked to Jul 2027 (12-month default), scored on the close that day.
TD Cowen’s track record →Call it yourself
No member calls on $EW yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Edwards Lifesciences →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.